focus neurogeriatrie

, Volume 1, Issue 1, pp 14–15

Jeder einzelne Risikofaktor zählt!

Effektive Schlaganfallprävention erfordert die Behandlung aller beeinflussbaren Risiken
  • B. Iglseder
Aktuelles
  • 6 Downloads

Literatur

  1. Goldstein LB, Adams R, Alberts MJ et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006; 113: e873–e923.PubMedCrossRefGoogle Scholar
  2. Cleeman JI, Grundy SM, Becker D et al. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama-Journal of the American Medical Association 2001; 285: 2486–2497.CrossRefGoogle Scholar
  3. Baigent C, Keech A, Kearney PM et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–1278.PubMedCrossRefGoogle Scholar
  4. Amarenco P, Bogousslavsky J, Callahan A, III et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–559.PubMedCrossRefGoogle Scholar
  5. Appel LJ, Moore TJ, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117–1124.PubMedCrossRefGoogle Scholar
  6. Sandhofer A, Iglseder B, Paulweber B, Ebenbichler CF, Patsch JR. Comparison of different definitions of the metabolic syndrome. Eur J Clin Invest 2007; 37: 109–116.PubMedCrossRefGoogle Scholar
  7. Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 2005; 36: 1212–1217.PubMedCrossRefGoogle Scholar
  8. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults – findings from the Third National Health and Nutrition Examination Survey. Jama-Journal of the American Medical Association 2002; 287: 356–359.CrossRefGoogle Scholar
  9. Toole JF, Malinow MR, Chambless LE. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The vitamin intervention for stroke prevention (VISP) randomized controlled trial. Journal of Vascular Surgery 2004; 39: 1356.CrossRefGoogle Scholar
  10. Lonn E, Yusuf S, Arnold MJ et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567–1577.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • B. Iglseder
    • 1
  1. 1.Christian-Doppler-KlinikUniversitätsklinik für GeriatrieSalzburg

Personalised recommendations